Dr Zaha on the Risk of Cardiovascular Toxicity in Patients With Lung Cancer

Commentary
Video
Conference|ACRO Summit

Vlad Gabriel Zaha, MD, PhD, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation.

Vlad Gabriel Zaha, MD, PhD, associate professor, Department of Internal Medicine, UT Southwestern Medical Center, member, Cardiology Division, Harold C. Simmons Comprehensive Cancer Center, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation. He emphasizes the importance of recognizing this risk in the treatment landscape.

Related Videos
Amma Asare, MD, PhD
Sundar Jagannath, MBBS
Elias Jabbour, MD
Rebecca Klisovic, MD
Axel Hauschild, MD, PhD, head, Skin Cancer Trial Center, University Hospital Schleswig-Holstein
David L. Porter, MD, director, Cell Therapy and Transplant, Jodi Fisher Horowitz Professor in Leukemia Care Excellence, Penn Medicine
Jubilee Brown, MD
Changchun Deng, MD, PhD
Laura J. Chambers, DO
Casey M. Cosgrove, MD
Related Content
FDA

SNB-101 Receives FDA Fast Track Designation for SCLC

May 10th 2024
Article
Hari B. Keshava, MD

Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection

October 23rd 2023
Podcast
Oluwaseun Orikogbo, MD

Time to Bladder Cancer Treatment Is Similar Among Black and White Patients, But Other Disparities Persist

May 6th 2024
Article
Adnan F. Danish, MD

Danish Discusses the Benefits of SCINTIX Biology-Guided Radiotherapy in Metastatic Lung and Bone Cancers

August 7th 2023
Podcast
Antoni Vilaseca Cabo, MD, of Hospital Clínic de Barcelona

TAR-210 Demonstrates Preliminary Efficacy in FGFR-Altered Non–Muscle-Invasive Bladder Cancer

May 5th 2024
Article
Vikram Narayan, MD

Nadofaragene Firadenovec Demonstrates Durable 5-Year Activity in NMIBC

May 5th 2024
Article